Clinical Trials Directory

Trials / Completed

CompletedNCT01371903

The Effects of Patient Features on Opioid Induced End-Tidal CO2

The Effect of Patient Features on Opioid Induced End-Tidal CO2

Status
Completed
Phase
Study type
Observational
Enrollment
278 (actual)
Sponsor
Albany Medical College · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.

Detailed description

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

Conditions

Timeline

Start date
2010-08-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2011-06-13
Last updated
2014-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01371903. Inclusion in this directory is not an endorsement.